Cargando…

The success of regorafenib in hepatocellular carcinoma in a world of failures. Learnings for future developments

Detalles Bibliográficos
Autores principales: Reig, Maria, Díaz-González, Álvaro, Bruix, Jordi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5739712/
https://www.ncbi.nlm.nih.gov/pubmed/29290927
http://dx.doi.org/10.18632/oncotarget.22382
_version_ 1783287922340921344
author Reig, Maria
Díaz-González, Álvaro
Bruix, Jordi
author_facet Reig, Maria
Díaz-González, Álvaro
Bruix, Jordi
author_sort Reig, Maria
collection PubMed
description
format Online
Article
Text
id pubmed-5739712
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Impact Journals LLC
record_format MEDLINE/PubMed
spelling pubmed-57397122017-12-29 The success of regorafenib in hepatocellular carcinoma in a world of failures. Learnings for future developments Reig, Maria Díaz-González, Álvaro Bruix, Jordi Oncotarget Editorial Impact Journals LLC 2017-11-11 /pmc/articles/PMC5739712/ /pubmed/29290927 http://dx.doi.org/10.18632/oncotarget.22382 Text en Copyright: © 2017 Reig et al. http://creativecommons.org/licenses/by/3.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0/) 3.0 (CC BY 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Editorial
Reig, Maria
Díaz-González, Álvaro
Bruix, Jordi
The success of regorafenib in hepatocellular carcinoma in a world of failures. Learnings for future developments
title The success of regorafenib in hepatocellular carcinoma in a world of failures. Learnings for future developments
title_full The success of regorafenib in hepatocellular carcinoma in a world of failures. Learnings for future developments
title_fullStr The success of regorafenib in hepatocellular carcinoma in a world of failures. Learnings for future developments
title_full_unstemmed The success of regorafenib in hepatocellular carcinoma in a world of failures. Learnings for future developments
title_short The success of regorafenib in hepatocellular carcinoma in a world of failures. Learnings for future developments
title_sort success of regorafenib in hepatocellular carcinoma in a world of failures. learnings for future developments
topic Editorial
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5739712/
https://www.ncbi.nlm.nih.gov/pubmed/29290927
http://dx.doi.org/10.18632/oncotarget.22382
work_keys_str_mv AT reigmaria thesuccessofregorafenibinhepatocellularcarcinomainaworldoffailureslearningsforfuturedevelopments
AT diazgonzalezalvaro thesuccessofregorafenibinhepatocellularcarcinomainaworldoffailureslearningsforfuturedevelopments
AT bruixjordi thesuccessofregorafenibinhepatocellularcarcinomainaworldoffailureslearningsforfuturedevelopments
AT reigmaria successofregorafenibinhepatocellularcarcinomainaworldoffailureslearningsforfuturedevelopments
AT diazgonzalezalvaro successofregorafenibinhepatocellularcarcinomainaworldoffailureslearningsforfuturedevelopments
AT bruixjordi successofregorafenibinhepatocellularcarcinomainaworldoffailureslearningsforfuturedevelopments